-
(R)-2,2′-Bis[di(3,5-dimethoxy
-
(R)-2,2′-Bis[di(3,5-dimethoxy
phenyl)phosphino]-6,6′-dimethoxy-1,1′-bi
phenyl,98%, 250mg
-
(S)-6,6′-Bis(bis(3,5-bis(trimethylsilyl)
phenyl)phosphino)-2,2’,3,3′-tetrahydro-5,5′-bibenzo[b][1,4]dioxine,98%, 100mg
-
(S)-6,6′-Bis(bis(3,5-bis(trimethylsilyl)
phenyl)phosphino)-2,2’,3,3′-tetrahydro-5,5′-bibenzo[b][1,4]dioxine,98%, 1g
-
(S)-6,6′-Bis(bis(3,5-bis(trimethylsilyl)
phenyl)phosphino)-2,2’,3,3′-tetrahydro-5,5′-bibenzo[b][1,4]dioxine,98%, 250mg
-
(4S,4’S)-2,2′-((
Phenylphosphanediyl)bis(2,1-
phenylene))bis(4-benzyl-4,5-dihydrooxazole),97%, 100mg
-
(4S,4’S)-2,2′-((
Phenylphosphanediyl)bis(2,1-
phenylene))bis(4-benzyl-4,5-dihydrooxazole),97%, 1g
-
(4S,4’S)-2,2′-((
Phenylphosphanediyl)bis(2,1-
phenylene))bis(4-benzyl-4,5-dihydrooxazole),97%, 250mg
-
(4S,4’S)-2,2′-((
Phenylphosphanediyl)bis(2,1-
phenylene))bis(4-cyclohexyl-4,5-dihydrooxazole),97%, 100mg
-
Chloro(4-cyano
phenyl){(R)-1-[(S)-2-(dicyclohexylphosphino)ferrocenyl]ethyl(dicyclohexylphosphine)}nickel(II),, 250mg
-
1-(3-fluorobenzyl)-1h-indazol-5-amine,≥95%, 250mg
-
(+)-Dihydrocarveol,≥95% (total amount of enantiomers, GC), 5ml
стр.: